ampelopsin has been researched along with Reperfusion Injury in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dinda, AK; Joshi, B; Reeta, KH; Sharma, U; Singh, D; Upadhyay, D; Wasan, H | 1 |
| Li, P; Liu, T; Wang, D; Xie, J; Xu, S; Zhang, T | 1 |
| Chen, J; Chen, Y; Chi, X; Guo, D; Jiang, Y; Jiang, Z; Lin, J; Lv, L; Pi, H; Qin, W; Yang, H | 1 |
3 other study(ies) available for ampelopsin and Reperfusion Injury
| Article | Year |
|---|---|
Dihydromyricetin alleviates cerebral ischemia-reperfusion injury by attenuating apoptosis and astrogliosis in peri-infarct cortex.
Topics: Animals; Apoptosis; Brain Ischemia; Cerebral Cortex; Disease Models, Animal; Flavonols; Gliosis; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Wistar; Reperfusion Injury | 2022 |
Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting SPHK1/mTOR Signaling and Targeting Ferroptosis.
Topics: Animals; Coenzyme A; Ferroptosis; Flavonols; Glucose; Infarction, Middle Cerebral Artery; Iron; Ligases; Lipids; Mammals; Oxygen; Phosphatidylethanolamine Binding Protein; Phospholipid Hydroperoxide Glutathione Peroxidase; Phosphotransferases (Alcohol Group Acceptor); Rats; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction; TOR Serine-Threonine Kinases; Water | 2022 |
Dihydromyricetin protects against liver ischemia/reperfusion induced apoptosis via activation of FOXO3a-mediated autophagy.
Topics: Animals; Apoptosis; Autophagy; Caspase 3; Disease Models, Animal; Flavonols; Forkhead Box Protein O3; Liver Diseases; Mice; Mice, Inbred C57BL; Phosphorylation; Protective Agents; Reperfusion Injury | 2016 |